Know Cancer

or
forgot password

Prospective Randomized Controlled Trial of Cap-Assisted ChromoEndoscopy(CapACE) Versus Conventional Colonoscopy(CC) for the Detection and 3-year Recurrence Rate of Colorectal Neoplasia


N/A
45 Years
75 Years
Open (Enrolling)
Both
Colorectal Neoplasm

Thank you

Trial Information

Prospective Randomized Controlled Trial of Cap-Assisted ChromoEndoscopy(CapACE) Versus Conventional Colonoscopy(CC) for the Detection and 3-year Recurrence Rate of Colorectal Neoplasia


Inclusion Criteria:



- All asymptomatic colonoscopic examinees

Exclusion Criteria:

- Familial history of hereditary colorectal cancer

- History of colorectal neoplasm

- Patients had received colonoscopy examination before

- Familial or past history of FAP(familiar adenomatous polyposis)

- Prior colonic resection

- Familial history of inflammatory bowel disease(IBD)

- Inflammatory bowel disease

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Outcome Measure:

Detection rate of colorectal neoplasia

Outcome Description:

7 days is needed to confirm the pathologic examination.

Outcome Time Frame:

7 days

Safety Issue:

No

Principal Investigator

Hyun Soo Kim

Investigator Role:

Principal Investigator

Investigator Affiliation:

Korean Association for the Study of Intestinal Diseases

Authority:

Korea: Institutional Review Board

Study ID:

KASID polyp-01

NCT ID:

NCT01112280

Start Date:

April 2010

Completion Date:

August 2015

Related Keywords:

  • Colorectal Neoplasm
  • Colorectal neoplasm
  • Colonoscopy
  • chromoendoscopy
  • cap-assisted colonoscopy
  • Neoplasms
  • Colorectal Neoplasms

Name

Location